Lawsuit challenges Louisiana law classifying mifepristone, misoprostol as controlled substances

Healthcare workers and advocates in Louisiana are challenging a law re-classifying medication abortion drugs as controlled substances, arguing it restricts access to essential care, particularly impacting Black women. The lawsuit seeks to halt enforcement of the law.